TrialDrug design, development and therapy2015

Clinical pharmacokinetics of AZD3199, an inhaled ultra-long-acting β2-adrenoreceptor agonist (uLABA).

Leif Bjermer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.